Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Racial/Ethnic Estimates of AD and Related Dementias

Alzheimers Dement; ePub 2018 Sep 19; Matthews, et al

Alzheimer disease and related dementias (ADRD) cause a high burden of morbidity and mortality in the US. This according to a recent study that estimated the future US burden of ADRD by age, sex, and race and ethnicity by applying subgroup-specific prevalence among Medicare Fee-for-Service beneficiaries aged ≥65 years in 2014 to subgroup-specific population estimates for 2014 and population projection data from the US Census Bureau for 2015 to 2060. Investigators found:

  • The burden of ADRD in 2014 was an estimated 5 million adults aged ≥65 years or 1.6% of the population, and there are significant disparities in ADRD prevalence among population subgroups defined by race and ethnicity.
  • ADRD burden will double to 3.3% by 2060 when 13.9 million Americans are projected to have the disease.

Matthews KA, Xu W, Gagliotti AH, et al. Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years. [Published online ahead of print September 19, 2018]. Alzheimers Dement. doi:10.1016/j.jalz.2018.06.3063.